Skip to main content
SpringerLink
Log in

Immunology and Liver

  • Book
  • © 2000

Overview

Editors:
  1. M. P. Manns

    1. Abt. Gastroenterologie/Hepatologie Zentrum Innere Medizin, Medizinische Hochscule Hannover, Hannover, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. G. Paumgartner

    1. Medizinische Klinik II, Klinikum Grosshadern der LMU München, München, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. U. Leuschner

    1. Abt. Gastroenterologie Zentrum der Innere Medizin, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt, Frankfurt, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Falk Symposium (FASS, volume 114)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (33 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Basic mechanisms of autoimmunity

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Autoimmunity and autoaggression

      • B. Arnold
      Pages 3-7

    3. Autoantibodies to insulin-like growth factor II mRNA-binding proteins in hepatocellular carcinoma

      • E. M. Tan, J.-Y. Zhang, E. K. L. Chan
      Pages 8-15

    4. Migration of microsomal autoantigens to the hepatocyte plasma membrane

      • D. Pessayre, V. Descatoire, P. Dansette, J. Loeper, A. Berson, M.-A. Robin
      Pages 16-34

    5. Caspase-10 mutations in the autoimmune lymphoproliferative syndrome type II

      • J. Wang, M. J. Lenardo
      Pages 35-45

    6. Mechanisms of virus-induced autoimmune disease

      • B. Ludewig, P. Aichele, R. M. Zinkernagel, H. Hengartner
      Pages 46-54

  3. Definition and spectrum of autoimmune hepatitis

    1. Front Matter

      Pages 55-55
      Download chapter PDF

    2. Definition and classification of autoimmune hepatitis 1999 (on behalf of the International Autoimmune Hepatitis Group)

      • I. G. McFarlane
      Pages 57-68

    3. Autoimmune hepatitis in Asia

      • M. Nishioka
      Pages 69-81

    4. Autoimmune hepatitis in South America

      • E. L. R. Cançado, G. Porta
      Pages 82-92

    5. Autoimmune hepatitis in children

      • F. Alvarez
      Pages 93-98

    6. Hepatitis in the polyendocrine syndrome type 1

      • P. Obermayer-Straub, M. P. Manns
      Pages 99-111

  4. Pathogenesis of autoimmune liver diseases

    1. Front Matter

      Pages 113-113
      Download chapter PDF

    2. Genetics of autoimmune liver disease

      • P. T. Donaldson
      Pages 115-132

    3. The role of T cells in autoimmune hepatitis

      • D. Vergani, G. Mieli-Vergani
      Pages 133-136

    4. ‘ANCA’ in liver diseases

      • B. Terjung, H. J. Worman
      Pages 137-151

    5. Reactivity of autoimmune hepatitis sera with glutathione S-transferase

      • J. Węsierska-Gądek, E. Penner
      Pages 152-163

  5. Drug and hepatitis virus induced autoimmunity

    1. Front Matter

      Pages 165-165
      Download chapter PDF

    2. The cytochrome P450 supergene family: genetic organization and function

      • K. J. Griffin, E. F. Johnson
      Pages 167-179
Back to top

Keywords

About this book

In 1992, the Falk Symposium No. 70 dealt with the topic `Immunology and Liver'. At that time basic mechanisms of immunology as well as immunopathogenetic mechanisms in viral and autoimmune liver diseases were discussed. Now, 7 years later, the Falk Symposium No. 114, held in Basel, Switzerland, October 20-21 1999 (Part I of the Basel Liver Week 1999), focused on immunology in autoimmune liver diseases. In the first section basic mechanisms of autoimmunity are presented, including the relevance of superantigens and the role of apoptosis. A further topic is the latest developments concerning animal models for autoimmune diseases. Recently the International Autoimmune Hepatitis Group newly defined and reclassified the syndrome of autoimmune hepatitis. Autoimmune hepatitis is now identified and studied in all parts of the world, including Asia and South America. A special variant of autoimmune hepatitis was identified as one organ manifestation of the autoimmune polyendocrine syndrome type 1, a genetic disease caused by mutations in a single transcription factor. Drug- and hepatitis-virus induced immune mediated liver diseases may serve as models for nonhepatic immune mediated disorders. DNA technology has increased our knowledge of the immunogenetic background of autoimmune liver diseases. Among the cholestatic immune mediated liver diseases, significant progress has been made concerning primary biliary cirrhosis, in particular regarding the identification of mitochondrial antigens and the characterisation of the immune reactions directed at them. The involvement of infectious agents in PBC as well as the definition of overlap syndromes is a particular focus for basic and clinical research in this area.
Concerning the therapy of autoimmune liver diseases, corticosteroids and azathioprin remain the state of the art for autoimmune hepatitis, while bile acids have become well established in treatment of primary biliary cirrhosis as wellas primary sclerosing cholangitis. New drugs in the future will include topical steroids such as budesonide and new immunosuppressive agents like mofetil/mycophenolate. Liver transplantation is the treatment of choice for end stage liver diseases; all autoimmune liver diseases are among the best candidates for liver transplantation. Hopefully, new therapeutic strategies based on the results obtained from experimental models will become everyday clinical practice in the next decade. Therefore this symposium concludes with a discussion.

Editors and Affiliations

  • Abt. Gastroenterologie/Hepatologie Zentrum Innere Medizin, Medizinische Hochscule Hannover, Hannover, Germany

    M. P. Manns

  • Medizinische Klinik II, Klinikum Grosshadern der LMU München, München, Germany

    G. Paumgartner

  • Abt. Gastroenterologie Zentrum der Innere Medizin, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt, Frankfurt, Germany

    U. Leuschner

Bibliographic Information

  • Book Title: Immunology and Liver

  • Editors: M. P. Manns, G. Paumgartner, U. Leuschner

  • Series Title: Falk Symposium

  • DOI: https://doi.org/10.1007/978-94-011-4000-3

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Kluwer Academic Publishers and Falk Foundation e.V. 2000

  • Hardcover ISBN: 978-0-7923-8759-6Published: 31 August 2000

  • Softcover ISBN: 978-94-010-5768-4Published: 22 November 2012

  • eBook ISBN: 978-94-011-4000-3Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XI, 400

  • Topics: Hepatology

Publish with us

Policies and ethics

Back to top

Search

Navigation